http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007070589-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ee0a9e6ec840f03ede278ff9c0837f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cf881a07459f16c3f4c1802dd639db9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e19f14fa192d54201ec149664e63da5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba99ab86cd9ca6f9d976b070fa5a6f51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e48bc8189ee94893eda0188f5998b5d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4df1080105c1e45e3d09635736a11d6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-09
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2006-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50af015b3d2a68c116f4cf3bd19c9e12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10872fb1e1244056972975b42934d606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6399a1d707508a54272400cac0a4d1a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2173d3fe239d96ef16552cc58b405aa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3372e638d8057cee9579b20ce33069cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_570f89cbd4ff0cd2802b80a73de2a652
publicationDate 2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007070589-A3
titleOfInvention Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1h-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine
abstract The instant disclosure provides crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine, salts and solvates thereof. The present disclosure also generally relates to pharmaceutical compositions comprising the crystalline form(s), as well of methods of using the crystalline form(s) in the treatment of HIV and/or AIDS, and methods for obtaining such crystalline form(s).
priorityDate 2005-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005209246-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227039364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11319217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419596140

Total number of triples: 33.